Company
Vytora Health
Recorded offers and program terms appear below. Check eligibility, billing periods and separate fees before comparing totals.
Published by Treatment Registry · Latest research
- 3 programs
- 2 identified molecules
- 6 readings
Read from vytorahealth.com; latest program check October 2026. Individual programs and sources may have earlier verification dates.
Go to Vytora Health
We earn nothing from this link. It opens Vytora Health's website without a paid referral.
Terms
- Pharmacy · By program
Public compounding network: Vials Pharmacy (Houston); Hallandale Pharmacy (Fort Lauderdale) — patient assignment not disclosed
compounded semaglutide (TR-0331) · compounded tirzepatide (TR-0332)
Evidence: October 2026
- Membership
None. “No membership or hidden fees”
Across recorded programs · Evidence: October 2026
- Consultation fee · By program
Included in program price; itemized amount not published. Physician consultation and unlimited support are explicitly included in the advertised plan; no additional consultation amount is itemized.
compounded semaglutide (TR-0331) · compounded tirzepatide (TR-0332)
Evidence: October 2026
Included in program price; itemized amount not published. The brand product pages explicitly include physician consultation and unlimited provider messaging.
Evidence: October 2026
- States · By program
All 50 states
compounded semaglutide (TR-0331) · compounded tirzepatide (TR-0332)
Evidence: October 2026
Programs
More columns to the right? Scroll across the table to see all details.
| Entry | Program | Form | Recorded price with its payment basis | Link |
|---|---|---|---|---|
| EntryTR-0331 | ProgramCompounded semaglutide | FormInjection, vial | Recorded price$179 Published figure · Advertised month-to-month semaglutide program Initial payment not verified Prescription required; advertised recurring plan. No selected invoice has been verified. Product pages say shipping included, while the separate shipping policy defers charges to checkout. | Record |
| EntryTR-0332 | ProgramCompounded tirzepatide | FormInjection, vial | Recorded price$249 Published figure · Advertised month-to-month tirzepatide program Initial payment not verified Prescription required; advertised recurring plan. No selected invoice has been verified. Product pages say shipping included, while the separate shipping policy defers charges to checkout. | Record |
| EntryTR-0333Not verified | ProgramBrand tirzepatide | FormInjection, pen | Recorded price$1,399 Historical recorded price · October 2026 · not currently verified Published figure · Mounjaro — advertised retail month-to-month program Initial payment not verified Prescription required. Advertised retail figure; insurance may change actual cost. No selected invoice or medication-specific assigned pharmacy is established; shipping-policy charge conflict remains. | Record |
Notes
Pricing details, service terms and questions to confirm before enrolling.
October 2026
- 1. Vytora says its advertised plans include medication, physician consultation, supplies and ongoing provider support, with no membership fee. It names Wasef Health as the clinical group. Most states can start without video; Kansas, Louisiana, Mississippi, New Mexico and West Virginia require a brief video or audio visit. Treatment and dose remain clinician-dependent. Sources: https://vytorahealth.com/ https://vytorahealth.com/faq
- 2. Product pages advertise free refill shipping, but the standalone shipping policy says charges are calculated at checkout. The policy estimates two-to-three-business-day processing and four-to-twelve-business-day shipping; no selected shipping charge is verified. The refund policy states prescription sales are final and filling errors should be reported to support. It does not establish the payment/refund result when no prescription is issued. Sources: https://vytorahealth.com/shipping https://vytorahealth.com/refund
Show 6 more notesHide 6 more notes
- 3. Compounded semaglutide product text establishes once-weekly subcutaneous injection and its own shipping instructions refer to the vial. The disclaimer says the artwork does not reflect the actual label or size of the prescription vial. Vial classification comes from this scoped text, not the image; brand, vial size, concentration and prescribed dose are not inferred. Public network lists Vials Pharmacy and Hallandale Pharmacy; an individual dispensing assignment is not given. Source: https://vytorahealth.com/semaglutide https://vytorahealth.com/
- 4. Compounded tirzepatide product text establishes once-weekly subcutaneous injection and its own shipping instructions refer to the vial. The disclaimer says the artwork does not reflect the actual label or size of the prescription vial. Vial classification comes from this scoped text, not the image; brand, vial size, concentration and prescribed dose are not inferred. Public network lists Vials Pharmacy and Hallandale Pharmacy; an individual dispensing assignment is not given. Source: https://vytorahealth.com/tirzepatide https://vytorahealth.com/
- 5. Compounded tirzepatide has conflicting one-month figures: the pricing card and product FAQ state $249; the general homepage/FAQ table states $199. The three-month plan prints $199/month and $599 billed every three months; these printed facts are retained without replacing the charge with an arithmetic product. Sources: https://vytorahealth.com/tirzepatide https://vytorahealth.com/
- 6. Brand tirzepatide catalog names Mounjaro and Zepbound; their own administration sections explicitly name prefilled pens. These are grouped under one brand-tirzepatide/pen record rather than duplicated by brand. The product pages contain inconsistent Mounjaro indication wording; this record does not adopt the provider’s claim of weight-loss approval, and no indication is inferred from marketing. The compounding network is not assigned as the dispenser of brand products. Sources: https://vytorahealth.com/mounjaro https://vytorahealth.com/zepbound
- 7. Vytora publishes conflicting brand-availability statements: its current homepage and dedicated Mounjaro and Zepbound pages advertise those prescriptions, while the compounded semaglutide page says “Vytora Health does not offer brand-name products.” The conflict is unresolved; confirm that the named brand is currently available before paying. The general all-state claim is not confirmation of brand-specific eligibility or dispensing, and the brand pages’ coverage answer refers to compounding-pharmacy partners. Brand-specific state availability remains unconfirmed. Sources: https://vytorahealth.com/semaglutide https://vytorahealth.com/mounjaro https://vytorahealth.com/zepbound
September 2026
- 8. The homepage publishes two different prices for the identical product in two places on the same page visit: the top pricing card lists Compounded Tirzepatide at '$249/month, billed monthly,' while the FAQ pricing table for the same product says '1-month: $199/mo · 3-month: $199/mo.' Compounded Semaglutide has a smaller but real gap too ($179 vs. $149 for a 3-month plan). Both figures are recorded rather than resolved by guessing which is authoritative. Mounjaro (labeled 'for type 2 diabetes') and Zepbound (labeled for weight loss) are both sold at the identical $1,399/month brand-tirzepatide retail price.
Understand the terms
- Billing periods and upfront charges
Separate the advertised rate from the payment and the period it covers.
- Consultations and their costs
Check which visits are included and which charges are separate.
- Understanding pharmacy disclosures
A named pharmacy or network does not establish who will fill your prescription.
Before you act
Cite this
Treatment Registry. (2026). Vytora Health: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/vytora-health